![](/img/cover-not-exists.png)
Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348)
Zhou, T, Georgeon, S, Moser, R, Moore, D J, Caflisch, A, Hantschel, OVolume:
28
Language:
english
Journal:
Leukemia
DOI:
10.1038/leu.2013.205
Date:
February, 2014
File:
PDF, 819 KB
english, 2014